Cargando…
Proof of the Concept to Use a Malignant B Cell Line Drug Screen Strategy for Identification and Weight of Melphalan Resistance Genes in Multiple Myeloma
In a conceptual study of drug resistance we have used a preclinical model of malignant B-cell lines by combining drug induced growth inhibition and gene expression profiling. In the current report a melphalan resistance profile of 19 genes were weighted by microarray data from the MRC Myeloma IX tri...
Autores principales: | Bøgsted, Martin, Bilgrau, Anders E., Wardell, Christopher P., Bertsch, Uta, Schmitz, Alexander, Bødker, Julie S., Kjeldsen, Malene K., Goldschmidt, Hartmut, Morgan, Gareth J., Dybkaer, Karen, Johnsen, Hans E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3869769/ https://www.ncbi.nlm.nih.gov/pubmed/24376673 http://dx.doi.org/10.1371/journal.pone.0083252 |
Ejemplares similares
-
Unaccounted uncertainty from qPCR efficiency estimates entails uncontrolled false positive rates
por: Bilgrau, Anders E., et al.
Publicado: (2016) -
Molecular Characteristics of High-Dose Melphalan Associated Oral Mucositis in Patients with Multiple Myeloma: A Gene Expression Study on Human Mucosa
por: Marcussen, Mette, et al.
Publicado: (2017) -
Exposure time independent summary statistics for assessment of drug dependent cell
line growth inhibition
por: Falgreen, Steffen, et al.
Publicado: (2014) -
MicroRNAs in B-cells: from normal differentiation to treatment of malignancies
por: Marques, Sara Correia, et al.
Publicado: (2014) -
Reproducible probe-level analysis of the Affymetrix Exon 1.0 ST array with R/Bioconductor
por: Rodrigo-Domingo, Maria, et al.
Publicado: (2014)